Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
APTA President’s Note | The Road Ahead

May 1, 2025/Column

Learn how APTA President Kyle Covington is thinking boldly about the future and every member's role in evolving our profession.

Researcher Spotlight

May 1, 2024/Column

Julie Fritz, PT, PhD, FAPTA, shares experiences translating research into practice and being a peer reviewer.

Laycock Pelvic Floor Manual Muscle Test Scale

Aug 23, 2017/Test & Measure

A 6 point Oxford scale (0=no contraction, 1=flicker, 2=weak, 3=moderate, 4=good (with lift), and 5=strong) used during internal examination to measure pelvic floor muscle strength in women. (4)

APTA-Backed Bill Presses for Medicare Advantage Prior Authorization Reforms

May 17, 2021/News

The legislation would require MA plans to share data, provide transparency, create more efficient systems, and do a better job of listening.

Researcher Spotlight

Dec 1, 2024/Article

Jim Gordon, PT, EdD, FAPTA, takes stock of his research journey and the challenges that remain.

Professionalism and Diversity Champion Samuel Feitelberg, PT, MA, FAPTA, Dies

Mar 24, 2023/News

A revered and influential teacher and clinician, Feitelberg served on the APTA Board of Directors in the early 1990s.

Making a Positive Impact on Healthy Body Image and Diet

Jun 29, 2021/Perspective

Current trends continually place an emphasis on unhealthy dietary habits and negative body image standards.

Children’s Assessment of Participation and Enjoyment/Preferences for Activities of Children (CAPE/PAC)

Jun 26, 2016/Test & Measure

The CAPE is a self-report measure of children’s participation in leisure and recreational activities.

Physical Therapist Management of Patients With or Recovering From COVID-19

Mar 1, 2023/Open Access

Access information and guidelines on COVID-19 based on national and international recommendations and guidelines.

Multiple Sclerosis in Adults: Management [NICE NG220]

Jun 22, 2022/CPG

This guideline covers diagnosing and managing multiple sclerosis in people aged 18 and over and aims to improve the quality of life for adults with multiple sclerosis. [Formerly NICE CG186.]